請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64311
標題: | 用以治療亨丁頓舞蹈症及癌症之雙重功能化合物
的設計與合成研究 Design and Synthesis of Dual-functional Compounds for Therapy of Huntington’s Disease and Cancers |
作者: | Jhih-Bin Chen 陳志彬 |
指導教授: | 方俊民(Jim-Min Fang) |
關鍵字: | Adenosine receptor,Equilibrative nucleoside transporter, 亨丁頓舞蹈症,腺嘌呤核苷,受體,平衡型核苷,轉運子, |
出版年 : | 2012 |
學位: | 博士 |
摘要: | In 2007, N6-(4-hydroxybenzyl)adenosine (T1-11, 16) was found to exert dual functions, acting as an agonist of adenosine A2A receptor and as an inhibitor of adenosine transporter (ENT1). This cooperative function of T1-11 effectively amplifies the activation of adenosinergic system in synapses. Therefore, T1-11 has potential to be developed to treat Huntington’s disease.
The constructed dual-pharmacophore model based on the known ligand structures of A2A receptor and ENT1 suggested the derivatization of hydrophobic moieties at the 5′-position of the lead compound, T1-11, in addition to the modification of 6-NH2 group. Thus, a series of T1-11 analogues were synthesized, and their pharmacological properties and neuroprotective activities were subsequently examined respectively by competitive radioligand binding assay and PC12 cell survival assay. These 5′-modified derivatives of T1-11 and its anisole analogue 19 generally showed somewhat decreased A2A agonism which accompanied by weaker neuroprotective activity. In contrast, these derivatives exhibited slightly better ENT1 inhibitory activity. Utilizing the fusing and merging strategies of the knowledge-based designed multiple ligands (DMLs) approach and Lipinski’s “Rule of Five”, we rationally designed the dual-functional compounds. We have synthesized a series of inhibitors and evaluated their biological activities, including the cytotoxicity and in vitro enzymatic and cell-based assays. All synthesized compounds, except for 137 and 139, exhibited dual inhibitory activities. In particular, 125, 126 and 128 showed selective toxicities against cancer cells. The in vivo animal assay is in progress. Photoprobe 142 was designed based on the structure of 104 and 105. This compound was synthesized and will be used in the photoaffinity labeling experiment in a due course. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64311 |
全文授權: | 有償授權 |
顯示於系所單位: | 化學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf 目前未授權公開取用 | 12.36 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。